In NASH mouse model, we demonstrated that miR-29aTg provides protective effect through suppressing TGF-β and SMAD3 [37], two critical positive regulator of HSC activation [156]. The gene discussed is TGFB1; the disease is metabolic dysfunction-associated steatohepatitis.